Get more replies from employers
Send a job-specific resume in minutes.
Tonix Pharmaceuticals is seeking an experienced Manager, Financial Reporting to lead the external financial reporting process and SEC compliance. The role focuses on preparing and reviewing SEC filings, maintaining documentation, and partnering with finance, legal, investor relations, and auditors.
The ideal candidate has deep SEC reporting expertise, strong technical accounting knowledge, and prior Big Four public accounting experience, with ability to manage multiple deadlines in a fast-paced
Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-BorreliaOspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company onLinkedIn andX .
*Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.
Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
Tonix Pharmaceuticals is seeking an experienced Manager, Financial Reporting to lead and manage the Company's external financial reporting process and SEC compliance activities. This role will be responsible for preparing and reviewing SEC filings, maintaining technical accounting documentation, supporting ad hoc reporting and analysis, and partnering cross-functionally with finance, legal, investor relations, and external auditors. The ideal candidate possesses deep SEC reporting expertise, strong technical accounting knowledge, and prior Big Four public accounting experience.
$100,000 - $133,000 USD
* Please note that Tonix does not offer sponsorship for this role.
Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes.
Tonix provides a comprehensive compensation and benefits package which includes:
Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law.